ArticleBreast care (Basel, Switzerland)2025
Risk Assessment Using Gene Expression Profiling Correlates with Clinical Prognosis Estimation in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer.
Alexa Binder et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.